MW
Matthew J. Whitney
ALLIANCEBERNSTEIN L.P.
Nashville, TN 37203
Some features on this profile are disabled
CRD#: 7083861
MW
Professional summary
Matthew John Whitney is a registered financial advisor currently at ALLIANCEBERNSTEIN L.P. located in Nashville, Tennessee and ALLIANCEBERNSTEIN INVESTMENTS, INC. located in Nashville, Tennessee.
Matthew is registered as an IAR (Investment Advisor Representative) and RR (Registered Representative) and started their career in finance in 2021. Matthew has worked at 2 firms and has passed the Series 66, Series 7TO and SIE exams.
Question & Answer
Are you a "fiduciary"?
Yes
Aliases
None
Other business activities
Outside business activity is any business or activity undertaken by an advisor that is outside the scope of their relationship with their firm (e.g., consulting services, real estate, freelance work, teaching, etc.). Investors should stay informed about these activities to ensure no conflicts of interest.
I worked as a consultant for Luma Therapeutics starting in 01/2019. I have since finished my project and have not worked for them since mid March 2019 right around when I started with AllianceBernstein. So currently I'm not devoting any hours to Luma. In the event I would have the opportunity to take on another project there I'd guess only an hour or two on the weekend would be spent for that.
I scrubbed data for them and worked on a powerpoint. Here is a link to a press release from them https://lumatherapeutics.com/illuvinate-positive-clinical-results/
Text below:
MILLBRAE, Calif. & WASHINGTON-(BUSINESS WIRE)-Luma Therapeutics, a company dedicated to eradicating suffering from inflammatory skin disease, today announced positive results from three clinical studies evaluating in-home treatment of patients with plaque psoriasis. Findings from the studies, which assessed the company's FDA-cleared illuvinate? System, were presented during the annual meeting of the American Academy of Dermatology Annual meeting in Washington, D.C.
The results of the third study, presented by Tina Bhutani, M.D., of the UCSF Medical Center in San Francisco, Calif., demonstrated significant improvement in symptoms and appearance for plaques treated with illuvinate, with healing that was maintained eight weeks following treatment.
The multi-site study measured clinical outcomes from 52 target psoriasis plaques in 26 patients, with an untreated plaque on each patient serving as the control. In the study, Target Plaque Assessment (TPA) score was assessed at the beginning of the study and over a period of six weeks while using illuvinate. This score included assessments of scale, redness and thickness of plaques. Findings showed a 66% reduction in TPA score at six weeks for plaques treated with illuvinate compared with a 15% reduction for untreated plaques. At 14 weeks (eight weeks following treatment), results showed a 70% reduction in TPA score, suggesting a therapeutic effect sustained beyond the treatment period. Nearly one-third of patients had complete clearance of plaque at 14 weeks.
"These data suggest that illuvinate provides Goeckerman-like healing for patients with plaque psoriasis, which continues even beyond the treatment period," said Dr. Bhutani. "I believe illuvinate offers an exciting new prospect for many patients looking for an alternative to biologics and creams."
"Psoriasis is a challenging condition to manage, and many patients feel disheartened by the inability to find a treatment option that works and provides lasting long relief," said Dr. Jeffrey Sugarman, M.D., Ph.D., of Redwood Family Dermatology who served as the principal investigator of the study. "I have been impressed by the results, and particularly the durability of results, that I have seen in patients who have used the system."
"As a psoriasis sufferer myself, I know the frustration these patients feel with the treatment options currently available to them," said founder and CEO Evan Anderson. "We are pleased that the positive results of these studies show illuvinate's innovative light therapy system delivers significant benefit including sustained, durable healing, suggesting that illuvinate has the potential to improve quality of life for these patients."
CRS (Client Relationship Summary) - RIA
Click below to view Matthew John Whitney's CRS (Customer Relationship Summary).
Certified licenses
Advisors may have various certifications and credentials from different organizations. AdvisorCheck highlights these seven certifications - AIF®, CFP®, ChFC®, CFA, CLU®, CIMA®, CPWA®
NoneExperience
Current
December 2, 2021 - Present
ALLIANCEBERNSTEIN L.P.
Office #1: 501 Commerce Street, Nashville, TN 37203RIA
CRD#: 108477
Nashville, TN
Current
March 19, 2021 - Present
ALLIANCEBERNSTEIN INVESTMENTS, INC.
Office #1: 501 Commerce Street, Nashville, TN 37203BD
CRD#: 14549
Nashville, TN
Primary Firm SEC Registration
This SEC-registered firm can serve clients nationwide. Some states may require the firm to submit a notice filing if the firm has more than 5 clients or a physical office there. You can view these state-level filings under the section titled "State Registrations and Notice Filings".
AL
ALLIANCEBERNSTEIN L.P.
ALLIANCE CAPITAL MANAGEMENT L P | ALLIANCEBERNSTEIN L.P.
CRD#: 108477 / SEC#: 801-56720
RIA
Registered Investment Advisory firm - (8/13/1999 Approved)State Registrations and Notice Filings
Listed states reflect where the advisor is authorized to serve clients under state regulations.
IAR
means the advisor is registered as an Investment Advisor Representative in this state and is authorized to provide investment advice to clients there.RR
indicates the advisor is registered as a Registered Representative in this state, allowing them to offer securities such as stocks, bonds, and mutual funds through a broker-dealer.Visual representation of state registrations
RR
Tennessee(12/2/2021)
IAR
Tennessee(12/2/2021)
Exams
State Security Law Exam
General Industry/Product Exam
RR
Series 7TO
Date: 3/18/2021
General Securities Representative ExaminationGeneral Industry/Product Exam
SRO Registrations
RR
FINRA
Current Firm
AL
ALLIANCEBERNSTEIN L.P.
ALLIANCE CAPITAL MANAGEMENT L P | ALLIANCEBERNSTEIN L.P.
CRD#: 108477 / SEC#: 801-56720
RIA
Registered Investment Advisory firm - (8/13/1999 Approved)Upgrade to AdvisorCheck Premium
Get A Biweekly Pulse, AutomaticallyReceive biweekly alerts automatically. Stay informed and proactive.
Catch Firm-Level Red Flags SoonerCatch leadership changes and disclosures early, before issues escalate.
See Trends. Not Just SnapshotsMonitor firm stability metrics like AUM and advisor ratios over time.
Contact information
Main Address
501 Commerce Street, Nashville, TN 37203
Mailing Address
Phone number
(615) 622-0000
Established
Firm type
Fiscal year end
# of Employees
3,994
SEC notice filing (51 States and Territories)
Regulatory assets under management
| Total Number of Accounts | 68,593 |
| AUM (Assets Under Management) | $ 709,162,000,000 |
Accountant surprise examination report
| Filing Date | Form ADV-E Cover | Form ADV-E Report |
|---|---|---|
| 11/25/2024 | ||
| 10/27/2023 |
Red Flags
Disclosures can be potential red flags, including customer disputes, regulatory fines, employer terminations, bankruptcies, judgments, liens, or certain criminal activities.
Check for any disclosures as part of your thorough research when choosing an advisor.
